1Anderson JL,Adams CD,Antman EM,et al.ACC/AHA2007 guidelines for the management of paints with unstable angina/non-ST-elevation myocardial infarction.J Am Coll Cardiol,2007,50(7):e1-e157
2Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American Documents.Circulation,2008,118(18):1894-1909
3Gilard M,Arnaud B,Le Gal G,et al.Influence of omeprazol on the anpiplatelet action of clopidogroi associated to aspirin.J Thromb Hacmost,2006,4(11):2508-2509
4Gilard M,Arnand B,Cornily JC,et al.Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized,doublehlind OCLA(Omeprazole CLopidogrel Aspirin)study.J Am Coll Cardiol,2008,51(3):256-260
5Food and Drug Administration.Early Communication about an ongoing safety review of clopidogrel bisulfate(marketed as Plavix).http://www.fda.gov/cder/drug/early comm/clopidogrel bisulfate.htm.Accessed January 26,2009
6Ho P.M,Maddox MT,Wang L et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndromes.JAMA,2009,301(9):937-944
8Juurlink DN,Gomes T,Ko DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.CMAJ,2009,180(7):699-700
9Geiger J,Brich J,Honig-Liedl P,et al.Specific impairment of human platelet P2Y(AC)ADP receptor2 mediated signaling by the antiplatelet drug clopidogrel.A rterioscler Thromb Vasc Biol,1999,19(8):2007-2011
10Savi P,Pereillo JM,Uzabiega MF,et al.Identification and biological activity of the active metabolite of clopidogsel.Thromb Hacmest,2000,84(5):891-896
